Prot#2011-002: Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients with Relapsed and Refractory Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date11/18/11 → 11/18/17

Funding

  • ACT Oncology, LLC (2011-002 // 2011-002)
  • Onyx Pharmaceuticals, Inc. (2011-002 // 2011-002)